Drainage and hormone treatment for large ovarian endometrioma cysts
Studies drainage plus hormone medicine for large ovarian cysts in women of childbearing age.
Key facts
- Who runs it
- University Hospital, Lille
- Where
- Lisle-sur-Tarn, FranceSee the site
- Trial code
- Registry title
- The Therapy of Large Endometrioma
- Status
- Recruiting
- People taking part
- 62 people, planned
- Started
- 21 Jan 2021
- Expected to end
- Dec 2026
- Type of study
- Observational
- Record updated
- 23 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women of childbearing age with a large ovarian endometrioma, a cyst of 6 cm (2.4 in) or more. It studies cyst drainage plus a GnRH agonist.
- Age
- 18 to 40 years
- Sex
- Women only
- Disease stage
- Endometrioma of 6 cm (2.4 in) or more, seen on MRI or ultrasound. One or both ovaries. May also have other endometriosis or adenomyosis.
Main reasons for not taking part
- Cyst with unusual (atypical) look on imaging or during laparoscopy
- Pregnancy
- Cannot take a GnRH agonist (Enantone® 3,75 mg or Decapeptyl® 3 mg)
- Cannot have laparoscopy
- Cannot have general anesthesia
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Endometrioma size ≥ 6cm determined by MRI or ultrasonography
- Women with isolated endometrioma or other extraovarian endometriosis: peritoneal, infiltrating endometriotic lesions and adenomyosis
- Cyst single or bilateral
Who cannot take part
- Cyst with radiographic or macroscopic in laparoscopy atypia
- Pregnancy
- Patient with contraindication to GnRH agonist (Enantone® 3,75 mg et Decapeptyl® 3 mg)
- Patient with contraindication to laparoscopy
- Patient with contraindication to general anesthesia
- Subject refusing to participate in the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Where in France
- Hop Jeanne de Flandre Chu LilleLisle-sur-Tarn, FranceContact: Chrytèle RUBOD, MD,PhDTaking people
About the trial
What the trial wants to find out
Endometrioma's prevalence is between 23 and 55%. It causes pelvic pain, decrease fertility and ovarian reserve.
Read full original descriptionShow less
Currently, there's no recommendation about large endometrioma's treatment and there's no information on the best treatment to limit recurrences, preserve fertility and ovarian reserve.
In Lille university hospital, simple laparoscopic drainage associated with hormonal therapy is practiced to reduce the risk of cystectomy.
This protocol will be evaluated with an observational and prospective study, including women of childbearing age having endometrioma measuring 6 cm or above.
The aim of this study is to assess if cyst drainage associated with GnRH agonist, could decrease endometrioma recurrences, deleterious effect on ovarian reserve and evaluate impact on anti-mullerian hormone
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluate the Therapy of Large Ovarian Endometrioma
- Plain-language title
- Drainage and hormone treatment for large ovarian endometrioma cystsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04704115, who can take part
- Record updated
- 23 December 2025